Century Therapeutics, Inc. (IPSC) Misses Q2 EPS by 6c

Century Therapeutics, Inc. (NASDAQ: IPSC) reported Q2 EPS of ($0.17), $0.06 worse than the analyst estimate of ($0.11).

For earnings history and earnings-related data on Century Therapeutics, Inc. (IPSC) click here.

You May Also Be Interested In

• Senior Iranian Official To Reuters: Tehran Is Reviewing U.S. Response To Its Proposal To End Hostilities
• Rubio: Iran Meeting Was Positive But Not A Breakthrough - Bloomberg
• Stitch Fix (SFIX) call put ratio 4.9 calls to 1 put with a focus on October 2.5 and 5 calls into quarter results